Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 34, Issue 6, Pages 942-952
Publisher
Wiley
Online
2014-01-17
DOI
10.1111/liv.12466
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma
- (2013) J-B Zhang et al. BRITISH JOURNAL OF CANCER
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Acidity Generated by the Tumor Microenvironment Drives Local Invasion
- (2013) V. Estrella et al. CANCER RESEARCH
- Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma
- (2013) Manabu Shigeoka et al. CANCER SCIENCE
- Cancer metabolism, stemness and tumor recurrence
- (2013) Joseph M. Curry et al. CELL CYCLE
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- CD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinoma
- (2012) Xu Tang et al. JOURNAL OF DRUG TARGETING
- Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
- (2012) Marco Gerlinger et al. JOURNAL OF PATHOLOGY
- Importance of glycolysis and oxidative phosphorylation in advanced melanoma
- (2012) Jonhan Ho et al. Molecular Cancer
- Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
- (2012) Vera Miranda-Gonçalves et al. NEURO-ONCOLOGY
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- (2011) Yoshihiro Komohara et al. CANCER SCIENCE
- Drug transporter expression in human macrophages
- (2011) Amélie Moreau et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
- (2011) Tineke W.H. Meijer et al. LUNG CANCER
- HAb18G/CD147 promotes epithelial–mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug
- (2011) J Wu et al. ONCOGENE
- Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
- (2011) Ken Shirabe et al. SURGERY TODAY
- Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma
- (2010) Kenji Yorita et al. LIVER INTERNATIONAL
- The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma
- (2009) Hirotake Takai et al. LIVER INTERNATIONAL
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
- (2008) Tong Ding et al. HUMAN PATHOLOGY
- Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection
- (2008) Yi-Wei Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started